Back to search

Article

Structure-based Generation of a Secondary Nucleation Inhibitor in α-Synuclein Aggregation Using a Conditional Diffusion Model

2025-08-17

Abstract excerpt

The process of α -synuclein aggregation results in the formation of amyloid fibrils, which accumulate in the brain of patients affected by Parkinson’s disease. Among possible therapeutic strategies to cure this disease, one approach is based on the development of compounds capable of inhibiting α -synuclein aggregation. An effective inhibition could be achieved by blocking the nucleation sites on the surface of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bf3ed79f-4936-5f36-b42b-0f0c35aa1af1
DOI
10.1101/2025.08.16.670694
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Structure-based Generation of a Secondary Nucleation Inhibitor in α-Synuclein Aggregation Using a Conditional Diffusion ModelDOI 10.1101/2025.08.16.670694
Select a neighboring publication to make it the new centre.